Bioequivalence Study of Pegylated Doxorubicin Hydrochloride Liposome (PEGADRIA) and DOXIL^® in Ovarian Cancer Patients: Physicochemical Characterization and Pre-clinical studies.

Velavan K⁷, Ahmad I^1*, Barkate HV³, Patel R¹¹, Kale P¹¹, Saptarishi D³, Mamillapalli G¹⁰, Singh JK⁹, Satheesh CT⁸, Ali SM¹, Kumar A⁶, Makadia RD⁵, Choudhury K⁴, Paithankar M³, Chen P², Ahmad MU¹, Ahmad A¹ and Sheikh S¹

¹Jina Pharmaceuticals Inc., 28100 Ashley Circle, Suite 103, Libertyville, IL 60048, USA

²Nia Life Sciences Inc, 28100 Ashley Circle, Suite 102, Libertyville, IL 60048, USA

³Intas Pharmaceuticals, Ahmedabad, Gujarat, India

⁴Health Point Multispeciality Hospital, Kolkata, West Bengal, India

⁵Shree Giriraj Multispeciality, Hospital, Rajkot, Gujarat, India

⁶Sapthagiri Institute of Medical Science and Research Centre, Karnataka, India

⁷Erode Cancer Centre, Erode, Tamilnadu, India

⁸Sri Venkateshwara Hospital, Bengaluru, Karnataka, India

⁹S. S Hospital and Research Centre, Patna, Bihar, India

¹⁰City Cancer Centre, Vijayawada, Andhra Pradesh, India

¹¹Lambda Therapeutic Research Ltd. Ahmedabad, Gujarat, India

^*Corresponding Author: